Cargando…

Gabapentin in Improvement of Procedural Sedation and Analgesia in Oncologic Pediatric Patients: A Clinical Trial

BACKGROUND: Preoperative anxiety and distress can produce significant psychological impacts on children undergoing oncologic care or investigation. Adjuvant therapy is used for pain management in children; however, pre-analgesia options are restricted because they can cause undesirable outcomes. OBJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto Filho, Washington Aspilicueta, Silveira, Lara de Holanda Juca, Vale, Mariana Lima, Fernandes, Claudia Regina, Gomes, Josenilia Alves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935294/
https://www.ncbi.nlm.nih.gov/pubmed/31903327
http://dx.doi.org/10.5812/aapm.91197
_version_ 1783483560021196800
author Pinto Filho, Washington Aspilicueta
Silveira, Lara de Holanda Juca
Vale, Mariana Lima
Fernandes, Claudia Regina
Gomes, Josenilia Alves
author_facet Pinto Filho, Washington Aspilicueta
Silveira, Lara de Holanda Juca
Vale, Mariana Lima
Fernandes, Claudia Regina
Gomes, Josenilia Alves
author_sort Pinto Filho, Washington Aspilicueta
collection PubMed
description BACKGROUND: Preoperative anxiety and distress can produce significant psychological impacts on children undergoing oncologic care or investigation. Adjuvant therapy is used for pain management in children; however, pre-analgesia options are restricted because they can cause undesirable outcomes. OBJECTIVES: Our study aimed to investigate the use of gabapentin in procedural sedation as adjuvant therapy in children undergoing oncologic treatment. METHODS: We performed a double-blinded, randomized, clinical trial at Albert Sabin Infant’s Hospital in Fortaleza, Brazil. Children aged 1 - 6 years who had myelogram or lumbar puncture (associated or not with intrathecal chemotherapy) received placebo or gabapentin syrups (15 mg/kg and 30 mg/kg) one to two hours before the procedure. Preoperative anxiety was evaluated by the Yale preoperative anxiety scale modified (m-YPAS scale). The pediatric anesthesia emergence delirium (PAED) and children and infants postoperative pain scale (CHIPP) scales were used for emergence delirium and pain intensity measurement, respectively. RESULTS: We evaluated 135 patients. We observed that the gabapentin groups presented lower m-YPAS scores than the placebo group at separation and induction times. Postoperatively, the gabapentin groups had lower PAED and CHIPP scores than the placebo group; however, only had PAED scores clinical relevance. No significant differences were found between the gabapentin groups. Furthermore, children with less than three prior similar procedures were more likely to benefit from gabapentin. Postoperative vomiting was prevented by 30 mg/kg gabapentin. CONCLUSIONS: Although gabapentin has little preoperative effects, it ameliorates anxiety before induction, improves anesthetic induction, and reduces the occurrence of emergence delirium and postoperative vomiting up to eight hours after the procedure. Thus, we indicate gabapentin as adjuvant therapy for procedural sedation.
format Online
Article
Text
id pubmed-6935294
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-69352942020-01-03 Gabapentin in Improvement of Procedural Sedation and Analgesia in Oncologic Pediatric Patients: A Clinical Trial Pinto Filho, Washington Aspilicueta Silveira, Lara de Holanda Juca Vale, Mariana Lima Fernandes, Claudia Regina Gomes, Josenilia Alves Anesth Pain Med Research Article BACKGROUND: Preoperative anxiety and distress can produce significant psychological impacts on children undergoing oncologic care or investigation. Adjuvant therapy is used for pain management in children; however, pre-analgesia options are restricted because they can cause undesirable outcomes. OBJECTIVES: Our study aimed to investigate the use of gabapentin in procedural sedation as adjuvant therapy in children undergoing oncologic treatment. METHODS: We performed a double-blinded, randomized, clinical trial at Albert Sabin Infant’s Hospital in Fortaleza, Brazil. Children aged 1 - 6 years who had myelogram or lumbar puncture (associated or not with intrathecal chemotherapy) received placebo or gabapentin syrups (15 mg/kg and 30 mg/kg) one to two hours before the procedure. Preoperative anxiety was evaluated by the Yale preoperative anxiety scale modified (m-YPAS scale). The pediatric anesthesia emergence delirium (PAED) and children and infants postoperative pain scale (CHIPP) scales were used for emergence delirium and pain intensity measurement, respectively. RESULTS: We evaluated 135 patients. We observed that the gabapentin groups presented lower m-YPAS scores than the placebo group at separation and induction times. Postoperatively, the gabapentin groups had lower PAED and CHIPP scores than the placebo group; however, only had PAED scores clinical relevance. No significant differences were found between the gabapentin groups. Furthermore, children with less than three prior similar procedures were more likely to benefit from gabapentin. Postoperative vomiting was prevented by 30 mg/kg gabapentin. CONCLUSIONS: Although gabapentin has little preoperative effects, it ameliorates anxiety before induction, improves anesthetic induction, and reduces the occurrence of emergence delirium and postoperative vomiting up to eight hours after the procedure. Thus, we indicate gabapentin as adjuvant therapy for procedural sedation. Kowsar 2019-10-28 /pmc/articles/PMC6935294/ /pubmed/31903327 http://dx.doi.org/10.5812/aapm.91197 Text en Copyright © 2019, Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Pinto Filho, Washington Aspilicueta
Silveira, Lara de Holanda Juca
Vale, Mariana Lima
Fernandes, Claudia Regina
Gomes, Josenilia Alves
Gabapentin in Improvement of Procedural Sedation and Analgesia in Oncologic Pediatric Patients: A Clinical Trial
title Gabapentin in Improvement of Procedural Sedation and Analgesia in Oncologic Pediatric Patients: A Clinical Trial
title_full Gabapentin in Improvement of Procedural Sedation and Analgesia in Oncologic Pediatric Patients: A Clinical Trial
title_fullStr Gabapentin in Improvement of Procedural Sedation and Analgesia in Oncologic Pediatric Patients: A Clinical Trial
title_full_unstemmed Gabapentin in Improvement of Procedural Sedation and Analgesia in Oncologic Pediatric Patients: A Clinical Trial
title_short Gabapentin in Improvement of Procedural Sedation and Analgesia in Oncologic Pediatric Patients: A Clinical Trial
title_sort gabapentin in improvement of procedural sedation and analgesia in oncologic pediatric patients: a clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935294/
https://www.ncbi.nlm.nih.gov/pubmed/31903327
http://dx.doi.org/10.5812/aapm.91197
work_keys_str_mv AT pintofilhowashingtonaspilicueta gabapentininimprovementofproceduralsedationandanalgesiainoncologicpediatricpatientsaclinicaltrial
AT silveiralaradeholandajuca gabapentininimprovementofproceduralsedationandanalgesiainoncologicpediatricpatientsaclinicaltrial
AT valemarianalima gabapentininimprovementofproceduralsedationandanalgesiainoncologicpediatricpatientsaclinicaltrial
AT fernandesclaudiaregina gabapentininimprovementofproceduralsedationandanalgesiainoncologicpediatricpatientsaclinicaltrial
AT gomesjoseniliaalves gabapentininimprovementofproceduralsedationandanalgesiainoncologicpediatricpatientsaclinicaltrial